LRP1B and hepatocellular carcinoma: Among the 366 HCC patients, 42 (11%) had changes in the LRP1B, including missense mutation (7.4%), splicing mutation (0.82%), truncation mutation (0.55%), amplification (0.27%) and deep deletion (3.0%) (Figure 7f, g).